Key result
Postpartum D-dimer ≥/L is linked to ~7.6-fold higher odds of puerperal VTE.
Why the study?
The study aimed to investigate d-dimer for predicting venous thromboembolism events during puerperium and to identify other associated risk factors.
Does a d-dimer ≥3.70 mg/L predict venous thromboembolism in postpartum women?
Cohort (n=16,127)
No
Does a d-dimer ≥3.70 mg/L predict venous thromboembolism in postpartum women?
A postpartum d-dimer ≥3.70 mg/L independently predicts VTE risk, providing a potential tool to stratify and manage high-risk patients during the puerperium.
Answers are grounded in this paper and cite their sources.
Postpartum d-dimer ≥3.70 mg/L was associated with VTE; hypothesis-generating for risk stratification and requires prospective validation before clinical use.
The aim of this study was to investigate the d-dimer for prediction of venous thromboembolism (VTE) events in puerperium and to identify other risk factors associated with the occurrence of VTE. This was a prospective observational cohort study, which included 16 127 women who gave birth after 28 weeks of gestation at Women's Hospital of Zhejiang University, School of Medicine, from January 2016 to December 2016. Data including basic maternal and fetal characteristics, pregnancy complications, and predictive biomarkers within postpartum 24 hours including d-dimer, platelet, and fibrinogen were collected for analyses. In the cohort study, 19 (0.12%) women were identified as VTE, including 1 pulmonary embolism event and 18 deep venous thrombosis events. The receiver operating characteristic curve analysis suggested the best cutoff point for d-dimer level within postpartum 24 hours was 3.695 mg/L, with a specificity of 75.5% and a sensitivity of 73.7%, and there was no statistical correlation between fibrinogen and VTE, as well as between platelets and VTE. On multivariate analysis, age ≥35 years (odds ratio [OR] = 2.895, 95% confidence interval [CI]: 1.079-7.773), scarred uterus (OR = 3.894, 95% CI: 1.234-12.282), intrauterine infection (OR = 7.214, 95% CI: 1.519-34.262), antiphospholipid syndrome (OR = 199.530, 95% CI: 15.152-2627.529), d-dimer ≥3.70 mg/L (OR = 7.573, 95% CI: 2.699-21.247), and emergency cesarean delivery (OR = 23.357, 95% CI: 2.819-193.508) were independently associated with VTE in puerperium. We concluded that d-dimer ≥3.70 mg/L was an independent predictor of VTE during puerperium and d-dimer testing was necessary for perinatal women.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2020) conducted a cohort in Postpartum women (puerperium) (n=16,127). d-dimer ≥3.70 mg/L within 24 hours postpartum vs. d-dimer <3.70 mg/L was evaluated on Venous thromboembolism (VTE) during puerperium (OR 7.573, 95% CI 2.699-21.247, p=<0.001). A d-dimer level of ≥/L within 24 hours postpartum was independently associated with an increased risk of venous thromboembolism during puerperium.
Synapse has enriched 10 related papers. Consider them for comparative context: